Mirum Pharmaceuticals
NASDAQ: MIRMSan Diego, US · Incorporated in Delaware · 5 known investors
Rare liver disease treatment company.
Founders & leadership
CP
Investors · 5
Chiesi VenturesBoston · $5M
RiverVest Venture PartnersSt. Louis · $500K – $3M
Frazier Life SciencesreportedPalo Altovia Patrick Heron · board
New Enterprise Associates (NEA)reportedMenlo Park · $200K – $40Mvia Ed Mathers · board
Norwest Venture PartnersreportedMenlo Park · $10M – $30Mvia Tiba Aynechi · board
Competitors · 1
by search overlapCompanies competing with Mirum Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Why Mirum Pharmaceuticals (MIRM) Is Down 6.4% After Raising 2026 Sales Outlook Amid Wider Losses – And What's Nextfinance.yahoo.com · Aug 2026
Mirum Pharmaceuticals (MIRM) Stock Looks Fairly Valued After Recent News - Simply Wall St Newssimplywall.st · Aug 2026
Mirum Pharmaceuticals (MIRM) Q2 2026 Earnings Call Transcript - AOLaol.com · Aug 2026
Mirum Pharmaceuticals Slides as FDA Feedback Clouds Volixibat Timeline | Quiver Quantitativequiverquant.com · Aug 2026Frequently asked questions
- What does Mirum Pharmaceuticals do?
- Rare liver disease treatment company.
- Who founded Mirum Pharmaceuticals?
- Mirum Pharmaceuticals was founded by Chris Peetz.
- Who are Mirum Pharmaceuticals's investors?
- Mirum Pharmaceuticals's investors include Chiesi Ventures, RiverVest Venture Partners, Frazier Life Sciences, New Enterprise Associates (NEA), Norwest Venture Partners.
- Where is Mirum Pharmaceuticals headquartered?
- Mirum Pharmaceuticals is headquartered in San Diego, US.